---
layout: post
title: "台湾疫苗记录卡将可标注国药、科兴"
date: 2021-10-19T08:40:34.755Z
author: 联合早报
from: https://www.zaobao.com/realtime/china/story20211019-1204781
tags: [ 联合早报 ]
categories: [ 联合早报 ]
---
<!--1634644800000-->
[台湾疫苗记录卡将可标注国药、科兴](https://www.zaobao.com/realtime/china/story20211019-1204781)
------

<div>
<p>对于台湾民众接种大陆冠病疫苗国药与科兴，未来返台将可注记在黄卡（台湾疫苗记录卡）的消息，台湾卫生福利部长陈时中今天接受访问时表示，这是针对事实认定有接种过这两支疫苗，但是否承认要另案研究。</p><p>根据中央社报道，有媒体在今天立法院院会前询问，目前黄卡可以注记国药和科兴，是否代表认可这两支疫苗，陈时中作出上述回答。</p><p>至于未来若有疫苗护照，民众接种国药跟科兴是否能使用，陈时中则说，整体运用仍要讨论。</p><section id="imu"><div id="dfp-ad-imu1">        </div></section><p>台北市长柯文哲昨天说，打高端但想出境的人，除依照每个国家规定外，其他办法去问陈时中。陈时中今天被问到此事时说，台湾跟美国要持续沟通，目前都还没完全定案。</p><p>至于侨胞如果已接种两剂疫苗，春节回台湾时是否比照机组员“5+9”的隔离方式。陈时中指出，回台湾的民众要考虑自己的抵抗力，以及施打疫苗情况、社区防疫能力，机组员的检疫是因应台湾经济需要，人数相对少且范围可控，两者思考点不一样。<br> </p>      <div id="innity-in-post"></div><div id="dfp-ad-midarticlespecial">        </div>      <a href="https://subscribe.sph.com.sg/promotions/zbpe-3-months-99-cents-promotion/?utm_campaign=zbpe399&utm_medium=sph-publication&utm_source=zb&utm_content=subscribelink-free-endofarticle" target="_blank"><img class="view-desktop lazyload  " data-src="https://static.zaobao.com/s3fs-public/freemium_images/20210901/paywall_desktop-zbpe399_2.png?dHEiGouxxZpWwWTJE04dyGyUN74JOU2z" alt style="width:100%;" pinger-seen="true" src="https://static.zaobao.com/s3fs-public/freemium_images/20210901/paywall_desktop-zbpe399_2.png?dHEiGouxxZpWwWTJE04dyGyUN74JOU2z" referrerpolicy="no-referrer"></a>      <a href="https://subscribe.sph.com.sg/promotions/zbpe-3-months-99-cents-promotion/?utm_campaign=zbpe399&utm_medium=sph-publication&utm_source=zb&utm_content=subscribelink-free-endofarticle" target="_blank"><img class="view-mobile lazyload " data-src="https://static.zaobao.com/s3fs-public/freemium_images/20210901/paywall_mobile-zbpe399_2.png?qZnBcIGCJvPR8A2IAZOZuOxdoGZDatiI" alt pinger-seen="true" src="https://static.zaobao.com/s3fs-public/freemium_images/20210901/paywall_mobile-zbpe399_2.png?qZnBcIGCJvPR8A2IAZOZuOxdoGZDatiI" referrerpolicy="no-referrer"></a>
</div>
